ECMO: Optimization of Its Use

Extracorporeal Membrane Oxygenation(ECMO): Optimization of Its Use

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02280460

Enrollment

921

Registered

2014-10-31

Start date

2014-09-30

Completion date

2024-05-29

Last updated

2024-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Membrane Oxygenation Complication

Brief summary

To create a local registry for ECMO patients.

Detailed description

To create a local registry of retrospective and prospective patients on ECMO at Spectrum Health, Butterworth campus in order to optimize the use of ECMO therapy and to create algorithms to estimate the prognosis. ECMO patients will be compared to a control group of patients. Patient mortality will be assessed in-house, at 48 hours, 3 months, and 1 year after the start of ECMO therapy.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \>18 * requiring ECMO. For the control,Patients without ECMO admited to ICU.

Exclusion criteria

* Age\<18 * Known prisoner of the state

Design outcomes

Primary

Measure	Time frame
All cause mortality	1 year

Secondary

Measure	Time frame
all cause mortality	48 hours
In-house mortality	30 day

Countries

United States

Outcome results